Cargando…
IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells
Multiple myeloma (MM) is a hematological malignancy originating from malignant and clonally expanding plasma cells. MM can be molecularly stratified, and its clonal evolution deciphered based on the Ig heavy and light chains of the respective malignant plasma cell clone. Of all MM subtypes, IgE type...
Autores principales: | Kehl, Niklas, Kilian, Michael, Michel, Julius, Wagner, Tim R, Uhrig, Sebastian, Brobeil, Alexander, Sester, Lilli-Sophie, Blobner, Sven, Steiger, Simon, Hundemer, Michael, Weinhold, Niels, Rippe, Karsten, Fröhling, Stefan, Eichmüller, Stefan B, Bunse, Lukas, Müller-Tidow, Carsten, Goldschmidt, Hartmut, Platten, Michael, Raab, Marc-Steffen, Friedrich, Mirco J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577923/ https://www.ncbi.nlm.nih.gov/pubmed/36252999 http://dx.doi.org/10.1136/jitc-2022-005815 |
Ejemplares similares
-
Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
por: Aslan, Katrin, et al.
Publicado: (2020) -
Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics
por: Tirier, Stephan M., et al.
Publicado: (2021) -
Dysfunctional dendritic cells limit antigen-specific T cell response in glioma
por: Friedrich, Mirco, et al.
Publicado: (2022) -
Genetically Modified Cellular Therapies for Malignant Gliomas
por: Kilian, Michael, et al.
Publicado: (2021) -
T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
por: Kilian, Michael, et al.
Publicado: (2022)